(Q41423113)

30 September 2017

1 reference

title

Liver regeneration: prospects for therapy based on new technologies (English)

1 reference

30 September 2017

M A Kay

1

1 reference

30 September 2017

N Fausto

series ordinal

2

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Trends in Molecular Medicine

30 September 2017

published in

1 reference

30 September 2017

volume

3

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

108-115

1 reference

Replacement of diseased mouse liver by hepatic cell transplantation

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Activation of Jun kinase is an early event in hepatic regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Liver regeneration 4: transcriptional control of liver regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Liver regeneration 3: Regulation of signal transduction during liver regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

c-Jun is essential for normal mouse development and hepatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Scatter factor/hepatocyte growth factor is essential for liver development

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Regulation of the transcription factors NF-kappa B and AP-1 by redox changes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Hepatocyte transplantation: Back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Beneficial Effect of S-Adenosylmethionine during both Cold Storage and Cryopreservation of Isolated Hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Proliferative response of hepatocytes transplanted into spleen or solid support

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Self-induced correction of the genetic defect in tyrosinemia type I

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Gene therapy for metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

A Modified Urokinase Plasminogen Activator Induces Liver Regeneration Without Bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

Early clinical experience with a hybrid bioartificial liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910062-9

7 January 2021

10.1016/S1357-4310(96)10062-9

Identifiers

DOI

1 reference

30 September 2017

1 reference